Apex Biotechnology Corp. (TPE:1733)

Apex Biotechnology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,193	3,009	4,028	2,554	2,599	2,354
Market Cap Growth	-25.31%	-25.31%	57.73%	-1.73%	10.38%	-16.91%
Enterprise Value	2,718	2,667	3,842	2,337	2,292	2,222
Last Close Price	31.95	30.10	39.06	23.57	22.83	19.85
PE Ratio	25.16	23.50	34.79	14.05	12.85	24.84
Forward PE	-	13.11	13.11	13.11	13.11	13.11
PS Ratio	1.72	1.62	2.40	1.14	1.22	1.17
PB Ratio	1.75	1.65	2.24	1.41	1.48	1.43
P/TBV Ratio	1.79	1.69	2.30	1.46	1.58	1.55
P/FCF Ratio	10.63	10.01	19.32	-	16.95	10.00
P/OCF Ratio	9.72	9.15	17.48	95.95	14.45	8.39
EV/Sales Ratio	1.47	1.44	2.29	1.04	1.08	1.11
EV/EBITDA Ratio	14.17	14.65	18.60	8.99	7.86	11.12
EV/EBIT Ratio	21.16	20.76	27.11	13.24	11.18	21.50
EV/FCF Ratio	9.05	8.88	18.43	-	14.95	9.44
Debt / Equity Ratio	0.07	0.07	0.09	0.10	0.16	0.31
Debt / EBITDA Ratio	0.64	0.64	0.71	0.67	0.95	2.48
Debt / FCF Ratio	0.41	0.41	0.74	-	1.86	2.18
Asset Turnover	0.79	0.79	0.70	0.87	0.80	0.73
Inventory Turnover	1.89	1.89	1.54	2.44	2.75	3.05
Quick Ratio	2.00	2.00	1.93	1.57	1.42	1.32
Current Ratio	3.44	3.44	3.93	2.90	2.24	1.91
Return on Equity (ROE)	7.07%	7.07%	6.40%	10.16%	11.90%	5.70%
Return on Assets (ROA)	3.40%	3.40%	3.68%	4.26%	4.81%	2.36%
Return on Capital (ROIC)	4.12%	4.12%	4.49%	5.47%	6.10%	2.90%
Return on Capital Employed (ROCE)	6.60%	6.60%	7.40%	9.10%	10.90%	5.80%
Earnings Yield	4.01%	4.25%	2.87%	7.12%	7.78%	4.03%
FCF Yield	9.41%	9.99%	5.18%	-0.39%	5.90%	10.00%
Dividend Yield	3.74%	3.99%	2.82%	5.94%	5.70%	5.54%
Payout Ratio	85.90%	85.90%	120.86%	71.48%	54.06%	115.98%
Buyback Yield / Dilution	-0.08%	-0.08%	0.34%	4.70%	6.53%	-0.05%
Total Shareholder Return	3.67%	3.91%	3.16%	10.64%	12.23%	5.49%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.